tiprankstipranks
Trending News
More News >
International Isotopes Inc. (INIS)
:INIS
US Market
Advertisement

International Isotopes (INIS) Price & Analysis

Compare
25 Followers

INIS Stock Chart & Stats

$0.06
>-$0.01(-1.97%)
At close: 4:00 PM EST
$0.06
>-$0.01(-1.97%)

INIS FAQ

What was International Isotopes Inc.’s price range in the past 12 months?
International Isotopes Inc. lowest stock price was $0.03 and its highest was $0.11 in the past 12 months.
    What is International Isotopes Inc.’s market cap?
    International Isotopes Inc.’s market cap is $29.05M.
      When is International Isotopes Inc.’s upcoming earnings report date?
      International Isotopes Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 25 days.
        How were International Isotopes Inc.’s earnings last quarter?
        International Isotopes Inc. released its earnings results on Aug 13, 2025. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
          Is International Isotopes Inc. overvalued?
          According to Wall Street analysts International Isotopes Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does International Isotopes Inc. pay dividends?
            International Isotopes Inc. does not currently pay dividends.
            What is International Isotopes Inc.’s EPS estimate?
            International Isotopes Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does International Isotopes Inc. have?
            International Isotopes Inc. has 528,104,100 shares outstanding.
              What happened to International Isotopes Inc.’s price movement after its last earnings report?
              International Isotopes Inc. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -9.091%.
                Which hedge fund is a major shareholder of International Isotopes Inc.?
                Currently, no hedge funds are holding shares in INIS

                Company Description

                International Isotopes Inc.

                International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Radiological Services segment provides flood source disposal and gemstones processing services. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. It sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.

                International Isotopes (INIS) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Talphera
                Prophase Labs
                Rockwell Med
                SCYNEXIS
                Aytu BioScience

                Ownership Overview

                11.41%<0.01%88.59%
                11.41% Insiders
                <0.01% Other Institutional Investors
                88.59% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis